Portal Hypertension Explained: A Simple Guide for Patients

Most people have never heard of the portal vein. Yet for over 300 million people worldwide living with chronic liver disease, this single vessel — and the pressure inside it — can determine whether they survive a routine night's sleep.

Portal hypertension is not just a scan finding. It is a pathophysiological cascade that, if unrecognized, terminates in variceal hemorrhage, refractory ascites, hepatic encephalopathy, or multi-organ failure. What makes it especially dangerous: it is almost completely silent until it is not.

This guide explains the science, the stakes, and the solutions — written for patients and families who deserve to understand what is happening inside them.

~90%	of portal hypertension cases are caused by cirrhosis — yet many patients are unaware they have liver disease at all.

20–30%

mortality risk from a first variceal bleeding episode — even with emergency intervention.

50%	of patients with compensated cirrhosis will develop varices within 10 years if untreated.

What Is Portal Hypertension?

Portal hypertension is increased blood pressure in the portal vein and the network of veins that carry blood from the stomach, intestines, spleen, and pancreas to the liver. The liver filters this blood before sending it back to the heart.

When blood flow through the liver is blocked or slowed, pressure builds in this system. To compensate, the body redirects blood through smaller veins. These veins can stretch and weaken, leading to swelling, fluid leakage into the abdomen, or life-threatening bleeding.

Who Can Get Portal Hypertension?- Causes

Portal hypertension is classified by the site of vascular obstruction, which has both diagnostic and therapeutic implications:

1. Pre-Hepatic (Before the Liver)

1. Pre-Hepatic (Before the Liver)

• Portal vein thrombosis: Often caused by prothrombotic states, intra-abdominal sepsis, or neonatal omphalitis. The liver is structurally normal — a critical distinction.

• Splenic vein thrombosis: Typically secondary to pancreatitis; causes isolated gastric varices without cirrhosis.

2. Intra-Hepatic — Pre-sinusoidal

• Schistosomiasis: Leading cause globally; Schistosoma mansoni eggs lodge in portal venules, triggering periportal fibrosis without significant hepatocellular dysfunction.

• Primary biliary cholangitis (PBC): Autoimmune destruction of intrahepatic bile ducts.

• Idiopathic non-cirrhotic portal hypertension (INCPH): An underdiagnosed entity, particularly in South and Southeast Asia.

3. Intra-Hepatic — Sinusoidal (Most Common)

• Cirrhosis: Accounts for 80–90% of all portal hypertension in Western populations. Alcohol, viral hepatitis (B and C), NASH/MAFLD — all roads lead to fibrosis, distorted sinusoidal architecture, and increased hepatic vascular resistance.

4. Post-Hepatic (After the Liver)

• Budd-Chiari syndrome: Hepatic vein thrombosis causing sinusoidal congestion and centrilobular necrosis.

• Congestive hepatopathy: Right-sided heart failure and constrictive pericarditis transmit elevated central venous pressure retrograde into hepatic sinusoids. 

Symptoms of Portal Hypertension

Portal hypertension often has no symptoms in its early stages. Many people already have the condition before they notice any signs.

Symptoms usually appear when enlarged veins, called varices, begin to leak or bleed. Signs include:

• Vomiting blood & stool

• Abdominal swelling due to fluid buildup

• Rapid weight gain from fluid retention

• Swelling in the legs and feet

• Confusion or difficulty concentrating

Even without symptoms, regular checkups are important because the condition can progress silently.

Potential Complications of Portal Hypertension

Reference table to the symptoms and complications

Complication	Clinical Presentation
Variceal Hemorrhage/Gastrointestinal bleeding	Hematemesis or melena; often massive. Hemodynamic instability. Medical emergency.
Ascites/ Swelling in the abdomen due to water	Abdominal distension, rapid weight gain, reduced diaphragmatic excursion, dyspnea. Spontaneous bacterial peritonitis (SBP) is a feared complication.
Hepatic Encephalopathy/ Cognitive changes	Spectrum from subtle cognitive impairment (minimal HE) to coma. Driven by hyperammonemia and systemic inflammation.
Hepatorenal Syndrome/ Kidney problems	Functional kidney failure in the setting of severe portal hypertension. Carries 90-day mortality >50% without intervention.
Hypersplenism/ Destruction of blood cells	Splenomegaly with thrombocytopenia, leukopenia, anemia.
Portopulmonary Hypertension/ Heart and Lung complications	Elevated pulmonary arterial pressure; contraindication to liver transplantation if severe.

Regular monitoring and early treatment are important to manage these risks and prevent serious complications.

How Is Portal Hypertension Diagnosed?

Doctors often suspect portal hypertension based on symptoms and physical signs. Direct pressure measurement is the most accurate test, but it is usually not required.

Clinical signs doctors look for:

• Enlarged veins (varices)- On endoscopy

• Enlarged spleen- Clinical examination and scans

• Fluid in the abdomen (ascites)- clinical examination and scans

• Gastrointestinal bleeding- Clinical presentation and endoscopy

• Low blood cell counts- Blood test

Diagnostic tests

Blood tests

Evaluate liver and kidney function and detect anemia or abnormal blood counts.

Imaging scans

Ultrasound, CT, or MRI can reveal liver scarring, enlarged organs, abnormal veins, and fluid buildup. Doppler ultrasound assesses blood flow.

Endoscopy

A thin camera examines the esophagus and stomach for bleeding veins and allows treatment during the procedure. Early testing helps prevent serious complications.

Gold Standard: Hepatic Venous Pressure Gradient (HVPG) Gradient (HVPG)

HVPG measurement via transjugular catheterisation remains the most accurate assessment of sinusoidal portal pressure. A wedged hepatic venous pressure (WHVP) minus free hepatic venous pressure (FHVP) >5 mmHg confirms portal hypertension. It is not routinely required but guides treatment decisions in clinical trials and complex cases. 

Other Non-Invasive Assessment

• Liver stiffness measurement (LSM): Transient elastography (FibroScan®) correlates strongly with portal pressure. LSM >20–25 kPa suggests clinically significant portal hypertension with high specificity.

• Spleen stiffness: An emerging adjunct that adds incremental diagnostic value.

Treatment Options for Portal Hypertension

Treatment focuses on reducing pressure in the portal vein and preventing complications.

Management is stratified by the presence and severity of complications. The overarching goals are to reduce portal pressure, prevent decompensation, and treat the underlying liver disease.

1. Primary Prophylaxis — Preventing the First Bleed

• Non-selective beta-blockers (NSBBs): These are blood pressure medications — propranolol, nadolol, and carvedilol — that work by slowing the heart and reducing blood flow into the liver's portal system, thereby lowering the pressure inside it. Think of it as turning down a tap: less inflow means less pressure buildup. Carvedilol is increasingly preferred

• Endoscopic variceal ligation (EVL): In this procedure, a doctor uses a flexible camera passed down the throat to place tiny rubber bands around swollen veins in the food pipe, cutting off their blood supply so they shrink and can no longer bleed.

2. Acute Variceal Hemorrhage/ Gastrointestinal bleeding  — Emergency Management

This is a medical emergency with a 6-week mortality of ~15–20% in contemporary series. The therapeutic sequence is:

• Hemodynamic resuscitation

• Medications : Terlipressin (preferred), somatostatin, or octreotide

• Antibiotic prophylaxis: IV ceftriaxone (or norfloxacin)

• Endoscopic therapy: Within  12 hours of stabilisation.

• Salvage TIPS: Pre-emptive TIPS (within 72 hours).

3. TIPS — Transjugular Intrahepatic Portosystemic Shunt

• A minimally invasive procedure that creates a new pathway for blood flow in the liver to reduce pressure.

4. BRTO — Balloon-Occluded Retrograde Transvenous Obliteration

A minimally invasive procedure where a thin tube is guided through a vein to reach and permanently seal off swollen stomach veins using a small balloon and a clotting agent — particularly effective when other treatments like TIPS fall short.

Variants of BRTO include PARTO (plug-assisted retrograde transvenous obliteration) and CARTO (coil-assisted RTO). These modifications have expanded eligibility and improved the safety profile of the procedure.

5. Management of Ascites — Targeted Interventions

A needle is used to drain large amounts of fluid from the abdomen, combined with a protein drip to prevent the body going into shock afterward — the first-line treatment when the abdomen is severely distended.

6. Management of Hepatic Encephalopathy

Rifaximin: An antibiotic tablet that reduces harmful bacteria in the gut, cutting down the toxins that reach the brain and cause confusion — cuts recurrence risk by over half.

Lactulose: A syrup that speeds up bowel movements, flushing out toxins before they are absorbed — the standard first treatment for confusion episodes.

LOLA (L-ornithine L-aspartate): A supplement that helps the body break down ammonia — the main toxin responsible for liver-related confusion — given as a drip in hospital or tablets at home.

Zinc: Most patients with cirrhosis are zinc-deficient; simple supplementation helps the liver process ammonia more effectively.

7. Surgical Shunts

Surgery to create a bypass channel that diverts blood around the liver to relieve pressure. Selective shunts (like the Warren shunt) do this while keeping some blood flowing through the liver, reducing the risk of confusion compared to total bypass procedures. Reserved for younger, otherwise stable patients at specialist centres.

8. Splenectomy and Splenic Artery Embolisation

• Splenic artery embolisation: A minimally invasive procedure that partially blocks blood flow to the spleen, reducing portal pressure and improving low blood counts — without removing the spleen.

• Splenectomy: Surgical removal of an enlarged, problematic spleen; used when other options have failed, though technically challenging in portal hypertension.

9. Liver Transplantation

The ONLY  permanent cure — replacing the diseased liver eliminates both the cause and the high portal pressure in one step. Patients should be referred early, as complications of portal hypertension directly affect priority on the waiting list. Procedures like TIPS, BRTO, and banding are used to keep patients stable until a donor liver becomes available.

Expert Care and Support At ALPS Clinic

The best way to manage portal hypertension is to treat liver disease early. Some causes can be improved with timely care:

• Alcohol-related or metabolic liver disease: A healthy diet, weight control, and avoiding alcohol can support liver health.

• Hepatitis C: Often curable with antiviral medications.

• Regular screening: Early testing helps detect problems before complications develop.

After treatment, regular follow-up is essential. During the first year, your doctor will schedule frequent visits to ensure treatment is working and to watch for complications. At ALPS Clinic, we provide comprehensive care for liver, pancreas, and biliary conditions, including advanced laparoscopic and robotic procedures when needed. Contact us today to schedule a consultation and learn about your treatment options.